In our study, the promoter methylation levels of ATXN3 and JOSD2 were lower expressed in these genes’ high mRNA expression group in TCGA HCC samples, while JOSD1 was highly expressed in the JOSD1 high expression group. The gene discussed is JOSD2; the disease is hepatocellular carcinoma.